Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ethan Strattan
Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) and Resting Lymphocyte Kinase (RLK) Using a Novel Covalent Inhibitor PRN694
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Inducible T Cell Kinase (ITK); IL-2
Science-Business eXchange
SRC-Induced Activation of Inducible T Cell Kinase (ITK) Requires Phosphatidylinositol 3-Kinase Activity and the Pleckstrin Homology Domain of Inducible T Cell Kinase
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Phase 1/1b Dose-Escalation Trial Evaluating Cpi-818, an Oral Interleukin-2-Inducible T-Cell Kinase Inhibitor, in Patients With Relapsed/Refractory T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Identification of Rlk, a Novel Protein Tyrosine Kinase With Predominant Expression in the T Cell Lineage
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Monochloramine Inhibits Phorbol Ester-Inducible Neutrophil Respiratory Burst Activation and T Cell Interleukin-2 Receptor Expression by Inhibiting Inducible Protein Kinase C Activity
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34
Angewandte Chemie
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent and Selective Covalent Inhibitor of Brutons Tyrosine Kinase
Targeting Tumour Microenvironment by Tyrosine Kinase Inhibitor
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Interleukin-2 Triggers a Novel Phosphatidylinositol 3-Kinase-Dependent MEK Activation Pathway.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
